Versigent Q2 2026 earnings: EBITDA margin expands on higher volumes

Versigent (NYSE: VGNT) reported second-quarter 2026 net sales of $2.444 billion, up 10.8% year over year, while diluted EPS increased to $1.64 from $1.51 for the quarter ended June 30. Adjusted EBITDA grew faster than revenue, rising 24.8% as its margin expanded by 120 basis points, although higher interest and tax expenses limited the improvement in GAAP net profitability. Versigent also raised its full-year sales guidance while leaving its adjusted EBITDA and free cash flow outlook unchanged.

Core earnings data

Reported sales growth was nearly 11%, but adjusted net sales growth was approximately 5% after excluding foreign currency and commodity movements. Higher volumes in North America and Asia Pacific supported the underlying increase, reflecting stronger customer demand despite lower global automotive production.

Adjusted EBITDA benefited from higher volumes and disciplined operating execution, even as commodity costs remained a headwind. GAAP operating income also increased, while free cash flow remained roughly unchanged because higher operating cash flow was offset by increased capital spending.

Adjusted net sales growth, adjusted diluted EPS, adjusted EBITDA and free cash flow are non-GAAP measures. For periods before the April 1, 2026 spin-off, Versigent calculated per-share figures using the 70.89 million ordinary shares outstanding immediately after the separation.

Operating gains were partly offset by interest and tax costs

Versigent’s operating results improved more sharply than its bottom line. Operating income rose to $199 million from $131 million, with the comparison also benefiting from the absence of the $25 million restructuring charge recorded a year earlier. This was partly offset by separation costs increasing to $22 million from $2 million.

Below operating income, interest expense climbed to $36 million from $1 million following the issuance of senior notes and establishment of a credit facility in the first quarter. Income tax expense also increased to $46 million from $21 million due to higher earnings and an unfavorable change in discrete tax items. Consequently, net income increased 10.3%, but net income margin edged down to 4.8% even as adjusted EBITDA margin expanded.

Cash flow, debt and capital allocation

Quarterly operating cash flow increased by $8 million to $158 million, while capital expenditures rose by $9 million to $51 million. The resulting $107 million of free cash flow was approximately flat and included $22 million of separation-related costs.

Versigent ended June with $554 million of cash and cash equivalents, compared with $276 million at the end of 2025. Total short- and long-term debt was approximately $2.224 billion, up from $61 million at year-end. During the first six months of 2026, the company received $2.063 billion of net proceeds from senior notes and its credit agreement and made a $1.894 billion cash distribution to its former parent.

The board also declared Versigent’s first quarterly dividend at $0.13 per ordinary share. It is payable on September 18, 2026, to shareholders of record on September 4, although future declarations remain subject to board approval and the company’s financial and cash requirements.

Full-year 2026 guidance

Versigent raised and narrowed its net sales range, increasing the midpoint by approximately $250 million. Management attributed the revision to higher commodity pass-throughs and foreign currency effects rather than a change in its adjusted EBITDA or free cash flow expectations.

Adjusted EBITDA and free cash flow guidance are forward-looking non-GAAP measures for which the company did not provide GAAP reconciliations.

Risks investors should monitor

• Reported growth depends partly on external pricing and currency effects. Adjusted sales growth was about 5%, compared with nearly 11% on a reported basis. Commodity and foreign exchange movements accounted for roughly six percentage points of the difference, and those factors also drove the higher sales outlook.
• Commodity costs continue to pressure profitability. Commodity pass-throughs can raise reported revenue, but management identified commodity costs as an adjusted EBITDA margin headwind.
• The post-spin capital structure has increased financing costs. Total debt rose substantially following the new notes and credit facility, and quarterly interest expense increased to $36 million from $1 million.
• Automotive production remains an important volume variable. Versigent generated higher volumes despite lower global automotive production, but a prolonged production downturn could make continued volume growth more difficult.
• Separation costs still affect cash generation. Second-quarter free cash flow included $22 million of separation-related spending as Versigent operates as an independent company.

Summary

Versigent’s second-quarter results combined higher underlying volumes with stronger operating profitability, lifting adjusted EBITDA margin even though commodity costs remained a headwind. Higher interest and tax expenses kept net margin from sharing that improvement, while free cash flow was stable amid increased capital spending and separation costs. The main issues to track are the balance between adjusted and externally driven sales growth, the effect of the new debt structure, and whether higher revenue guidance eventually translates into a higher profit or cash flow outlook.